Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Offering SPR-BLI Services - Proteins provided for free! Offering SPR-BLI Services - Proteins provided for free!
Thank you for choosing ACROBiosystems. Would you rate our product and service? Thank you for choosing ACROBiosystems. Would you rate our product and service?
Here come GMP Grade Cytokines!Free Sample is available! Here come GMP Grade Cytokines!Free Sample is available!
Captured Human TSLP (R127A, R130A), His Tag (Cat. No. TSP-H52Ha) on CM5 Chip via anti-His antibody, can bind Human TSLP R, Fc Tag (Cat. No. TSR-H525a) with an affinity constant of 4.22 nM as determined in SPR assay (Biacore T200) (Routinely tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Tezepelumab | AMG-157; MEDI-9929 | Approved | Amgen Inc | Tezspire | Japan | Asthma | Astrazeneca Kk | 2021-12-17 | Eosinophilic Esophagitis; Dermatitis, Atopic; Hypersensitivity; Pulmonary Disease, Chronic Obstructive; Bronchial Diseases; Hypersensitivity, Immediate; Sinusitis; Respiratory Hypersensitivity; Asthma; Lung Diseases, Obstructive; Immune System Diseases; Lung Diseases; Respiratory Tract Diseases; Nasal Polyps; Nose Diseases; Chronic Urticaria; Anaphylaxis; Carcinoma | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
AZD-8630 | AZD-8630; AMG-104 | Astrazeneca Plc, Amgen Inc | Details | ||
BSI-045B | BSI-045B | Boaoxin Biotechnology(Nanjing) Co Ltd | Details | ||
SAR-443765 | SAR-443765 | Phase 1 Clinical | Sanofi | Inflammation | Details |
MK-8226 | MK-8226 | Merck & Co Inc | Details | ||
ASP-7266 | UPB-101; ASP-7266 | Phase 1 Clinical | Astellas Pharma Inc, Upstream Biosciences Inc | Asthma | Details |
QX-008N | QX-008N; QX008N | Phase 1 Clinical | Qyuns Therapeutics Co Ltd | Asthma | Details |
HBM-9378 | SKB378; HBM-9378 | Phase 1 Clinical | Harbour Biomed, Sichuan Kelun-Biotech Biopharmaceutical Co Ltd | Asthma | Details |
GR-1802 | GR-1802 | Phase 2 Clinical | Zhixiang (Shanghai) Pharmaceutical Technology Co Ltd | Asthma; Sinusitis; Dermatitis, Atopic | Details |
Ecleralimab | CSJ-117; NOV-14 | Phase 2 Clinical | Novartis Pharma Ag | Asthma; Pulmonary Disease, Chronic Obstructive | Details |
SHR-1905 | SHR-1905 | Phase 2 Clinical | Shanghai Hengrui Pharmaceutical Co Ltd | Asthma | Details |
CM-326(Connaught Biomedical Technology) | CM-326 | Phase 2 Clinical | Keymed Biosciences Co Ltd | Nose Diseases; Nasal Polyps; Sinusitis; Asthma; Pulmonary Disease, Chronic Obstructive; Dermatitis, Atopic | Details |
This web search service is supported by Google Inc.